Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human soluble Fc-gamma receptor IIb

EU orphan designation number: EU/3/07/462   
Active ingredient: Recombinant human soluble Fc-gamma receptor IIb
Indication: Treatment of idiopathic thrombocytopenic purpura
Sponsor: Baxalta Innovations GmbH
Industriestraße 67, 1221 Wien, Österreich

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/08/2007 Orphan designation EMEA/OD/028/07 (2007)3817 of 02/08/2007
01/10/2007 Corrigendum (2007)3817 cor of 27/09/2007
23/09/2013 Change of name and/or address of sponsor
12/06/2017 Transfer of orphan designation EMA/OD/028/07/T/01 (2017)4084 of 08/06/2017